- Ropinirole
-
- $31.00 / 25mg
-
2026-04-22
- CAS:91374-21-9
- Min. Order:
- Purity: 99.68%
- Supply Ability: 10g
- Ropinirole
-
- $0.00 / 1KG
-
2025-12-12
- CAS:91374-21-9
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 1KG 100KG 1MT
- Ropinirole
-
- $90.00 / 1kg
-
2024-08-12
- CAS:91374-21-9
- Min. Order: 1kg
- Purity: 99.99%
- Supply Ability: 2000kg
|
| | Ropinirole Basic information |
| | Ropinirole Chemical Properties |
| Melting point | 243-250°C | | Boiling point | 410.5±45.0 °C(Predicted) | | density | 1.040±0.06 g/cm3(Predicted) | | pka | 14.17±0.20(Predicted) | | CAS DataBase Reference | 91374-21-9(CAS DataBase Reference) |
| | Ropinirole Usage And Synthesis |
| Chemical Properties | Ropinirole Hydrochloride: C16H24N2O·HCl. [91374-20-8]. Crystallized from acetonitrile, melting point 241-243°C. | | Uses | Antiparkinsonian (D2receptor agonist). | | Definition | ChEBI: Ropinirole is a member of indolones and a tertiary amine. It has a role as a dopamine agonist, an antiparkinson drug, a central nervous system drug and an antidyskinesia agent. | | Brand name | Requip (GlaxoSmithKline). | | Synthesis Reference(s) | Journal of Medicinal Chemistry, 28, p. 1533, 1985 DOI: 10.1021/jm00148a028 | | Clinical Use |
Anti-Parkinson agent
Restless legs syndrome (RLS) | | Drug interactions | Potentially hazardous interactions with other drugs
Antipsychotics: antagonism of anti-Parkinsonian
effect - avoid.
Metoclopramide: antagonism of anti-Parkinsonian
effect - avoid.
Oestrogens: concentration increased. | | Metabolism | Ropinirole is hepatically metabolised by the cytochrome
P450 enzyme, CYP1A2, and excreted in the urine as
inactive metabolites. |
| | Ropinirole Preparation Products And Raw materials |
|